Citadel Advisors reported a 5.6% stake in Aardvark Therapeutics AARD · 1,192,971 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.6%
Last report: First report
Shares held: 1,192,971 sh
Class: Common Stock, par value $0.00001 per share (the "Shares")
Stock: Aardvark Therapeutics AARD
Holder: Citadel Advisors
Event date: 25/02/14
Filed: 25/02/24

First 5%+ report · 5.6% stake

Aardvark Therapeutics trades, last 26 weeks

What else happened in Aardvark Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/15~25/03/16

Citadel Advisors's other 5% stake reports

Citadel Advisors
5% stakeVenu Holding
5% stake
Venu Holding
VENU
3.8% stake
2,365,505 sh
3.8% stake
Filed 08/14
Citadel Advisors
5% stakeSpruce Biosciences
5% stake
Spruce Biosciences
SPRB
1.9% stake
51,919 sh
1.9% stake
Filed 08/14
Citadel Advisors
5% stakeMomentus
5% stake
Momentus
MNTS
1.6% stake
309,865 sh
1.6% stake
Filed 08/14
Citadel Advisors
5% stakeXCHG
5% stake
XCHG
XCH
9.7% stake
272,656,440 sh
9.7% stake
Filed 08/14
Citadel Advisors
5% stakeVillage Farms International
5% stake
Village Farms International
VFF
5.5% stake
6,689,240 sh
5.5% stake
Filed 08/14